Centre National de la Recherche Scientifique Unité Mixte de Recherche 5203, Institut de Génomique Fonctionnelle, F-34000 Montpellier, France.
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3047-52. doi: 10.1073/pnas.1109457109. Epub 2012 Feb 6.
β-Arrestins (Arrb) participate in the regulation of multiple signaling pathways, including Wnt/β-catenin, the major actor in human colorectal cancer initiation. To better understand the roles of Arrb in intestinal tumorigenesis, a reverse genetic approach (Arrb(-/-)) and in vivo siRNA treatment were used in Apc(Δ14/+) mice. Mice with Arrb2 depletion (knockout and siRNA) developed only 33% of the tumors detected in their Arrb2-WT littermates, whereas Arrb1 depletion remained without significant effect. These remaining tumors grow normally and are essentially Arrb2-independent. Unsupervised hierarchical clustering analysis showed that they clustered with 25% of Apc(Δ14/+);Arrb2(+/+) tumors. Genes overexpressed in this subset reflect a high interaction with the immune system, whereas those overexpressed in Arrb2-dependent tumors are predominantly involved in Wnt signaling, cell adhesion, migration, and extracellular matrix remodeling. The involvement of Arrb2 in intestinal tumor development via the regulation of the Wnt pathway is supported by ex vivo and in vitro experiments using either tumors from Apc(Δ14/+) mice or murine Apc(Min/+) cells. Indeed, Arrb2 siRNAs decreased the expression of Wnt target genes in cells isolated from 12 of 18 tumors from Apc(Δ14/+) mice. In Apc(Min/+) cells, Arrb2 siRNAs completely reversed the increased Wnt activity and colony formation in soft agar induced by Apc siRNA treatment, whereas they did not affect these parameters in basal conditions or in cells expressing constitutively active β-catenin. We demonstrate that Arrb2 is essential for the initiation and growth of intestinal tumors displaying elevated Wnt pathway activity and identify a previously unsuspected molecular heterogeneity among tumors induced by truncating Apc mutations.
β-arrestins (Arrb) 参与多种信号通路的调节,包括 Wnt/β-catenin,这是人类结直肠癌起始的主要因素。为了更好地了解 Arrb 在肠道肿瘤发生中的作用,我们在 Apc(Δ14/+)小鼠中使用了反向遗传方法 (Arrb(-/-)) 和体内 siRNA 治疗。Arrb2 缺失 (敲除和 siRNA) 的小鼠仅发展出其 Arrb2-WT 同窝仔鼠中检测到的肿瘤的 33%,而 Arrb1 缺失仍然没有显著影响。这些剩余的肿瘤正常生长,基本上与 Arrb2 无关。无监督层次聚类分析显示,它们与 25%的 Apc(Δ14/+);Arrb2(+/+) 肿瘤聚类。这个亚组中上调的基因反映了与免疫系统的高度相互作用,而在 Arrb2 依赖性肿瘤中上调的基因主要涉及 Wnt 信号转导、细胞黏附、迁移和细胞外基质重塑。通过调节 Wnt 通路,Arrb2 参与肠道肿瘤的发生,这得到了使用 Apc(Δ14/+) 小鼠的肿瘤或鼠 Apc(Min/+) 细胞的离体和体外实验的支持。事实上,Arrb2 siRNAs 降低了从 18 个 Apc(Δ14/+) 小鼠肿瘤中分离的 12 个细胞中 Wnt 靶基因的表达。在 Apc(Min/+) 细胞中,Arrb2 siRNAs 完全逆转了由 Apc siRNA 处理诱导的 Wnt 活性和软琼脂集落形成的增加,而在基础条件下或表达组成型活性 β-catenin 的细胞中,它们不影响这些参数。我们证明 Arrb2 对于显示升高的 Wnt 通路活性的肠道肿瘤的起始和生长是必需的,并确定了由截短 Apc 突变诱导的肿瘤之间以前未被怀疑的分子异质性。